- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Taiwanese Pharmaceuticals & Biotech Dividend Powerhouses (3%+ Yield)
Results
6
This screener pinpoints dividend all-stars that boast strong fundamentals with yields typically exceeding 3%.
6 companies
PharmaEngine
Market Cap: NT$9.7b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$67.80
7D
0.9%
1Y
-18.3%
Standard Chemical & Pharmaceutical
Market Cap: NT$10.1b
Standard Chemical & Pharmaceutical Co. Ltd.
1720
NT$56.60
7D
0.5%
1Y
-12.8%
YungShin Global Holding
Market Cap: NT$15.1b
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.
3705
NT$56.80
7D
1.6%
1Y
1.6%
TTY Biopharm
Market Cap: NT$19.4b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$77.90
7D
1.4%
1Y
6.3%
SYN-TECH Chem. & Pharm
Market Cap: NT$3.5b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$79.30
7D
5.3%
1Y
-16.0%
Sinphar PharmaceuticalLtd
Market Cap: NT$6.0b
Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.
1734
NT$31.45
7D
1.8%
1Y
2.9%